Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease

Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration

Original post: February 14, 2015

• Franco Cavaleri1, ,

• Brain Research Center UBC Hospital 2211 Westbrook Mall Van BC V6T 2B5, Canada

Received 7 September 2014, Accepted 30 January 2015, Available online 7 February 2015Direct LINK to Journal Entry: http://www.sciencedirect.com/science/article/pii/S0306987715000651